Medicinal Plant Research 2024, Vol.14, No.5, 259-274 http://hortherbpublisher.com/index.php/mpr 268 bioactive compounds from degradation. Furthermore, clinical trials are necessary to evaluate the safety and efficacy of these pharmaceuticals in human populations. As seen in clinical trials involving Sanghuangporus extracts, standardized formulations can be tested in randomized, controlled studies to determine therapeutic dosages and effects (Ryu et al., 2022). 6.3 Regulatory and standardization challenges One of the major challenges in developing Sanghuangporus into functional foods and pharmaceuticals is the lack of standardized extraction methods and quality control protocols. The bioactive compound content in Sanghuangporus extracts can vary significantly depending on factors such as the extraction method, solvent used, and source of the mushroom. Therefore, establishing standardized extraction and processing methods is crucial to ensure consistent quality, safety, and efficacy of Sanghuangporus products. Additionally, the regulatory requirements for dietary supplements and pharmaceuticals differ across countries, posing another challenge in bringing Sanghuangporus-based products to the market. In many regions, dietary supplements are regulated less stringently than pharmaceuticals. However, for Sanghuangporus to be marketed as a dietary supplement or functional food, manufacturers must comply with safety, labeling, and health claims regulations. For pharmaceuticals, Sanghuangporus products must undergo rigorous clinical trials to demonstrate their safety and efficacy, followed by approval from regulatory agencies such as the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA). These regulatory hurdles necessitate a comprehensive understanding of local and international regulations to navigate the path to market successfully. 6.4 Market potential and consumer acceptance The market potential for Sanghuangporus-based products is promising, given the growing consumer interest in natural health products and the increasing prevalence of chronic diseases. The global market for functional foods and dietary supplements has been expanding, driven by the demand for natural and preventive healthcare solutions. Sanghuangporus, with its array of health benefits, is well-positioned to capture a share of this market. Consumer acceptance of Sanghuangporus products is likely to be favorable, especially among those seeking natural remedies for health maintenance and disease prevention. Its historical use in traditional medicine and emerging scientific evidence of its health benefits can enhance consumer trust and appeal. Effective marketing strategies are vital for consumer acceptance and market penetration of Sanghuangporus products. Educating consumers about the health benefits, safety, and scientific backing of Sanghuangporus can help build confidence and encourage usage. Collaboration with healthcare professionals to recommend Sanghuangporus-based supplements as part of a holistic health regimen can further boost consumer acceptance. Additionally, positioning Sanghuangporus products as part of a healthy lifestyle, alongside other functional foods and supplements, can attract health-conscious consumers. In addition, attention should be given to the application for unique Sanghuangporus brand trademarks, aiming to establish a brand owned by the nation. This effort will further accelerate the industrialization of Sanghuangporus, with the expectation of the emergence of a dedicated and trustworthy brand for consumers in the near future. In summary, the development of Sanghuangporus into functional foods and pharmaceuticals presents a multifaceted opportunity. By addressing standardization and regulatory challenges and leveraging its therapeutic potential, Sanghuangporus-based products can be successfully integrated into the health and wellness market, offering consumers natural options for disease prevention and health promotion. 7 Limitations and Challenges 7.1 Current gaps in research Sanghuangporus spp. is categorized as a minor agricultural product, with its large-scale commercialization developing relatively late. Its rapid development is constrained by limited wild resources, immature artificial cultivation techniques, insufficient efforts in the development of value-added products, and inadequate research into its medicinal mechanisms. Despite the promising pharmacological properties of Sanghuangporus, several
RkJQdWJsaXNoZXIy MjQ4ODYzNA==